2025/04/08

NEWrelease

Announcement of Application for Approval of Manufacturing and Marketing of Human (Allogeneic) iPS Cell-derived Cardiomyocyte Patches

2024/12/23

release

Announcement of Joint Research Agreement with Stanford University’s Department of Cardiothoracic Surgery(December 23, 2024 update)

2024/12/17

release

Announcement of Joint Research Agreement with Stanford University’s Department of Cardiothoracic Surgery

2023/11/15

release

Announcement of Presentation at AHA (American Heart Association) Scientific Session

2023/11/14

release

Cuorips awarded to occupy at METI’s new business center in Silicon Vallery

2023/06/27

release

Cuorips listed on the Tokyo Stock Exchange Growth Market

2022/08/29

release

An article in which our CTO Yoshiki Sawa commented was published in the website of “nature” .

2022/04/13

release

Announcement of Joint Research Agreement 　Regarding New Therapeutic Approach against Cardiovascular Diseases

2021/09/03

release

Announcement of New Chief Technology Officer (CTO): Pro. Yoshiki Sawa

2021/03/16

release

Private Placement of New Shares

2020/12/04

news

Private Placement of New Shares

2020/09/23

release

Cuorips officially commenced operations at its new state-of-the-art commercial cell processing facility

2020/03/02

release

Cuorips Started Construction of Cell Culture Processing Facility for Commercial Production

2018/07/11

news

Announcement of Third-Party Allocation of New Shares